|
US2004A
(en)
*
|
|
1841-03-12 |
|
Improvement in the manner of constructing and propelling steam-vessels |
|
US2005A
(en)
*
|
|
1841-03-16 |
|
Improvement in the manner of constructing molds for casting butt-hinges |
|
US2006A
(en)
*
|
|
1841-03-16 |
|
Clamp for crimping leather |
|
US4331647A
(en)
|
1980-03-03 |
1982-05-25 |
Goldenberg Milton David |
Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4603044A
(en)
|
1983-01-06 |
1986-07-29 |
Technology Unlimited, Inc. |
Hepatocyte Directed Vesicle delivery system
|
|
AU584417B2
(en)
|
1985-04-01 |
1989-05-25 |
Lonza Group Ag |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
ATE87659T1
(de)
|
1986-09-02 |
1993-04-15 |
Enzon Lab Inc |
Bindungsmolekuele mit einzelpolypeptidkette.
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US5567584A
(en)
|
1988-01-22 |
1996-10-22 |
Zymogenetics, Inc. |
Methods of using biologically active dimerized polypeptide fusions to detect PDGF
|
|
DE68926888T2
(de)
|
1988-01-22 |
1997-01-09 |
Zymogenetics Inc |
Verfahren zur Herstellung von sekretierten Rezeptoranalogen
|
|
EP0436597B1
(en)
|
1988-09-02 |
1997-04-02 |
Protein Engineering Corporation |
Generation and selection of recombinant varied binding proteins
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
WO1991010737A1
(en)
|
1990-01-11 |
1991-07-25 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
DE69122313T2
(de)
|
1990-06-21 |
1997-03-20 |
Honeywell Inc |
Auf variablem Horizont basierende adaptive Steuerung mit Mitteln zur Minimierung der Betriebskosten
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
|
DK0580737T3
(da)
|
1991-04-10 |
2004-11-01 |
Scripps Research Inst |
Heterodimere receptorbiblioteker ved anvendelse af phagemider
|
|
CA2110799A1
(en)
|
1991-06-14 |
1992-12-23 |
Arnold H. Horwitz |
Microbially-produced antibody fragments and their conjugates
|
|
DE69232137T2
(de)
|
1991-11-25 |
2002-05-29 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
EP0733070A1
(en)
|
1993-12-08 |
1996-09-25 |
Genzyme Corporation |
Process for generating specific antibodies
|
|
PT1231268E
(pt)
|
1994-01-31 |
2005-11-30 |
Univ Boston |
Bancos de anticorpos policlonais
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
JP4046354B2
(ja)
|
1996-03-18 |
2008-02-13 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
増大した半減期を有する免疫グロブリン様ドメイン
|
|
EP1500329B1
(en)
|
1996-12-03 |
2012-03-21 |
Amgen Fremont Inc. |
Human antibodies that specifically bind human TNF alpha
|
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US6057127A
(en)
*
|
1998-01-29 |
2000-05-02 |
Heska Corporation |
Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
|
|
US7198789B2
(en)
*
|
1998-03-17 |
2007-04-03 |
Genetics Institute, Llc |
Methods and compositions for modulating interleukin-21 receptor activity
|
|
US6057128A
(en)
*
|
1998-03-17 |
2000-05-02 |
Genetics Institute, Inc. |
MU-1, member of the cytokine receptor family
|
|
US20010023070A1
(en)
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
|
CA2329274A1
(en)
*
|
1998-05-29 |
1999-12-02 |
Steven M. Ruben |
Interleukin-21
|
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
|
EP1881070B1
(en)
|
1999-03-09 |
2012-10-03 |
Zymogenetics, Inc. |
Human cytokine as ligand of the zalpha receptor and uses thereof
|
|
US6307024B1
(en)
|
1999-03-09 |
2001-10-23 |
Zymogenetics, Inc. |
Cytokine zalpha11 Ligand
|
|
US7135287B1
(en)
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
|
ES2279809T3
(es)
|
2000-04-05 |
2007-09-01 |
Zymogenetics, Inc. |
Receptores de citoquina zalfa11 solubles.
|
|
DE60140474D1
(de)
|
2000-09-08 |
2009-12-24 |
Univ Zuerich |
Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
|
|
DE10047189C1
(de)
|
2000-09-23 |
2002-02-21 |
Bosch Gmbh Robert |
Verfahren zur Insassenklassifikation mit einer Sitzmatte im Fahrzeugsitz
|
|
PT1355919E
(pt)
|
2000-12-12 |
2011-03-02 |
Medimmune Llc |
Moléculas com semivida longa, composições que as contêm e suas utilizações
|
|
DK1451322T3
(da)
*
|
2001-11-05 |
2010-02-01 |
Zymogenetics Inc |
Il-21-antagonister
|
|
US20040028665A1
(en)
|
2002-01-08 |
2004-02-12 |
Garner Bryan E. |
Compositions and methods for inhibiting pathogenic growth
|
|
CA2481304A1
(en)
|
2002-03-27 |
2003-10-09 |
Patrick Hwu |
Method for treating cancer in humans
|
|
WO2003087320A2
(en)
|
2002-04-09 |
2003-10-23 |
Beth Israel Deaconess Medical Center, Inc. |
Antagonists of il-21 and modulation of il-21-mediated t cell responses
|
|
US20040016010A1
(en)
*
|
2002-04-17 |
2004-01-22 |
Marion Kasaian |
IL-21 receptor knockout animal and methods of use thereof
|
|
MXPA04012116A
(es)
|
2002-06-07 |
2005-04-19 |
Zymogenetics Inc |
Uso del il-21 en cancer y otras aplicaciones terapeuticas.
|
|
WO2004003156A2
(en)
|
2002-07-01 |
2004-01-08 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Il-21 as a regulator of immunoglobin production
|
|
CN1688340A
(zh)
*
|
2002-07-15 |
2005-10-26 |
韦思公司 |
调节t辅助(th)细胞发育和功能的方法和组合物
|
|
CN101972478B
(zh)
|
2002-10-08 |
2012-10-31 |
免疫医疗公司 |
抗体治疗
|
|
US20070092485A1
(en)
|
2002-11-15 |
2007-04-26 |
Zymogenetics, Inc. |
Cytokine zalpha11 ligand
|
|
JP3979276B2
(ja)
*
|
2002-11-29 |
2007-09-19 |
富士通株式会社 |
業務支援方法、業務支援装置、及びプログラム
|
|
ES2334127T3
(es)
|
2002-12-13 |
2010-03-05 |
Zymogenetics, Inc. |
Produccion de il-21 en huespedes procariotas.
|
|
WO2004056392A1
(en)
|
2002-12-23 |
2004-07-08 |
Innate Pharma |
Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same
|
|
CA2518371A1
(en)
*
|
2003-03-14 |
2004-09-30 |
Wyeth |
Antibodies against human il-21 receptor and uses therefor
|
|
KR20060015482A
(ko)
*
|
2003-03-21 |
2006-02-17 |
와이어쓰 |
인터루킨-21/인터루킨-21 수용체의 작용제를 이용한면역장애의 치료
|
|
JP2007508332A
(ja)
|
2003-10-17 |
2007-04-05 |
ノボ ノルディスク アクティーゼルスカブ |
併用療法
|
|
JP4471721B2
(ja)
|
2004-04-20 |
2010-06-02 |
独立行政法人産業技術総合研究所 |
抗インターロイキン２１受容体（ｉｌ−２１ｒ）抗体および本抗体を産生するハイブリドーマ
|
|
US20060024268A1
(en)
*
|
2004-05-19 |
2006-02-02 |
Wyeth |
Modulation of immunoglobulin production and atopic disorders
|
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
|
CA2574848A1
(en)
*
|
2004-08-05 |
2006-12-21 |
Wyeth |
Antagonizing interleukin-21 receptor activity
|
|
ITRM20040586A1
(it)
*
|
2004-11-29 |
2005-02-28 |
Giuliani Spa |
Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico.
|
|
WO2006105538A2
(en)
|
2005-03-31 |
2006-10-05 |
Centocor, Inc. |
Methods and compositions for treating il-21 related pathologies
|
|
DK200501310A
(da)
|
2005-09-21 |
2005-10-01 |
Novo Nordisk As |
The invention relates to the treatment or prevention of autoimmune diseases and latent autoimmune diabetes in the adults
|
|
AU2006341398B9
(en)
*
|
2005-11-28 |
2012-02-02 |
Zymogenetics, Inc. |
IL-21 receptor antagonists
|
|
AU2006340750B2
(en)
|
2005-11-28 |
2013-03-07 |
Zymogenetics, Inc. |
IL-21 antagonists
|
|
EP3103813A1
(en)
|
2007-12-07 |
2016-12-14 |
ZymoGenetics, Inc. |
Anti-human il-21 monoclonal antibodies
|
|
WO2009132821A1
(en)
|
2008-04-28 |
2009-11-05 |
Giuliani International Limited |
Interleukin (il-21) binding proteins and methods of making and using same
|
|
JP2014506259A
(ja)
|
2011-01-17 |
2014-03-13 |
ノヴォ ノルディスク アー／エス |
Ｉｌ−２１リガンド
|